Latest Articles
Endometrial Cancer in 2026: A practical update for Irish clinicians - imt.ie
Endometrial Cancer in 2026: A practical update for Irish clinicians imt.ie
Published: July 30, 2026, 10:09 a.m.
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer - OncLive
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer OncLive
Published: July 29, 2026, 5:21 p.m.
Q&A: Are environmental chemicals and endometrial cancer linked? - The Pennsylvania State University
Q&A: Are environmental chemicals and endometrial cancer linked? The Pennsylvania State University
Published: July 28, 2026, 1 p.m.
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial - Yahoo Finance
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial Yahoo Finance
Published: July 27, 2026, 10:08 p.m.
Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer - RSVP Live
Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer RSVP Live
Published: July 24, 2026, 6:04 p.m.
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators - Escuela Andaluza de Salud Pública
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Escuela Andaluza de Salud Pública
Published: July 22, 2026, 9:19 a.m.
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial - BioPharm International
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial BioPharm International
Published: July 16, 2026, 9:06 p.m.
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily
Published: July 16, 2026, 4:40 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm
Published: July 16, 2026, 10:27 a.m.
Link copied to clipboard!